Resultados da pesquisa - Saunders, Mark P

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials Por Renehan, Andrew G, Egger, Matthias, Saunders, Mark P, O'Dwyer, Sarah T

Obter o texto integral Obter o texto integral

The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer Por Kochhar, Rohit, Renehan, Andrew G., Mullan, Damian, Chakrabarty, Bipasha, Saunders, Mark P., Carrington, Bernadette M.

Obter o texto integral Obter o texto integral Obter o texto integral

Is monitoring of plasma 5-fluorouracil levels in metastatic / advanced colorectal cancer clinically effective? A systematic review Por Freeman, Karoline, Saunders, Mark P., Uthman, Olalekan A., Taylor-Phillips, Sian, Connock, Martin, Court, Rachel, Gurung, Tara, Sutcliffe, Paul, Clarke, Aileen

Obter o texto integral Obter o texto integral Obter o texto integral

Genome Scale Reconstruction of a Salmonella Metabolic Model: COMPARISON OF SIMILARITY AND DIFFERENCES WITH A COMMENSAL Escherichia coli STRAIN Por AbuOun, Manal, Suthers, Patrick F., Jones, Gareth I., Carter, Ben R., Saunders, Mark P., Maranas, Costas D., Woodward, Martin J., Anjum, Muna F.

Obter o texto integral Obter o texto integral Obter o texto integral

Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study Por Sekhar, Hema, Kochhar, Rohit, Carrington, Bernadette, Kaye, Thomas, Tolan, Damian, Saunders, Mark P., Sperrin, Matthew, Sebag-Montefiore, David, van Herk, Marcel, Renehan, Andrew G.

Obter o texto integral Obter o texto integral Obter o texto integral

Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990–2014) Por Sekhar, Hema, Malcomson, Lee, Kochhar, Rohit, Sperrin, Matthew, Alam, Nooreen, Chakrbarty, Bipasha, Fulford, Paul E., Wilson, Malcolm S., O’Dwyer, Sarah T., Saunders, Mark P., Renehan, Andrew G.

Obter o texto integral Obter o texto integral Obter o texto integral

Clinical and radiomics prediction of complete response in rectal cancer pre-chemoradiotherapy Por Mbanu, Peter, Saunders, Mark P., Mistry, Hitesh, Mercer, Joe, Malcomson, Lee, Yousif, Saif, Price, Gareth, Kochhar, Rohit, Renehan, Andrew G., van Herk, Marcel, Osorio, Eliana Vasquez

Obter o texto integral Obter o texto integral Obter o texto integral

Early adaptation of colorectal cancer cells to the peritoneal cavity is associated with activation of ‘stemness’ programs and local inflammation Por Barriuso, Jorge, Nagaraju, Raghavendar T., Belgamwar, Shreya, Chakrabarty, Bipasha, Burghel, George, Schlecht, Helene, Foster, Lucy, Kilgour, Elaine, Wallace, Andrew J., Braun, Michael, Dive, Caroline, Evans, D. Gareth, Bristow, Robert, Saunders, Mark P., O’Dwyer, Sarah T., Aziz, Omer

Obter o texto integral Obter o texto integral Obter o texto integral

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct Por Rao, Sheela, Sclafani, Francesco, Eng, Cathy, Adams, Richard A., Guren, Marianne G., Sebag-Montefiore, David, Benson, Al, Bryant, Annette, Peckitt, Clare, Segelov, Eva, Roy, Amitesh, Seymour, Matt T., Welch, Jack, Saunders, Mark P., Muirhead, Rebecca, O’Dwyer, Peter, Bridgewater, John, Bhide, Shree, Glynne-Jones, Rob, Arnold, Dirk, Cunningham, David

Obter o texto integral Obter o texto integral Obter o texto integral

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer Por Iveson, Timothy J., Sobrero, Alberto F., Yoshino, Takayuki, Souglakos, Ioannis, Ou, Fang-Shu, Meyers, Jeffrey P., Shi, Qian, Grothey, Axel, Saunders, Mark P., Labianca, Roberto, Yamanaka, Takeharu, Boukovinas, Ioannis, Hollander, Niels H., Galli, Fabio, Yamazaki, Kentaro, Georgoulias, Vassilis, Kerr, Rachel, Oki, Eiji, Lonardi, Sara, Harkin, Andrea, Rosati, Gerardo, Paul, James

Obter o texto integral Obter o texto integral Obter o texto integral

Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer Por Gray, Victoria, Briggs, Sarah, Palles, Claire, Jaeger, Emma, Iveson, Timothy, Kerr, Rachel, Saunders, Mark P, Paul, James, Harkin, Andrea, McQueen, John, Summers, Matthew G, Johnstone, Elaine, Wang, Haitao, Gatcombe, Laura, Maughan, Timothy S, Kaplan, Richard, Escott-Price, Valentina, Al-Tassan, Nada A, Meyer, Brian F, Wakil, Salma M, Houlston, Richard S, Cheadle, Jeremy P, Tomlinson, Ian, Church, David N

Obter o texto integral Obter o texto integral Obter o texto integral

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer Por Jayson, Gordon C., Zhou, Cong, Backen, Alison, Horsley, Laura, Marti-Marti, Kalena, Shaw, Danielle, Mescallado, Nerissa, Clamp, Andrew, Saunders, Mark P., Valle, Juan W., Mullamitha, Saifee, Braun, Mike, Hasan, Jurjees, McEntee, Delyth, Simpson, Kathryn, Little, Ross A., Watson, Yvonne, Cheung, Susan, Roberts, Caleb, Ashcroft, Linda, Manoharan, Prakash, Scherer, Stefan J., del Puerto, Olivia, Jackson, Alan, O’Connor, James P. B., Parker, Geoff J. M., Dive, Caroline

Obter o texto integral Obter o texto integral Obter o texto integral

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial Por Iveson, Timothy J, Kerr, Rachel S, Saunders, Mark P, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Scudder, Claire, Boyd, Kathleen Anne, Briggs, Andrew, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James

Obter o texto integral Obter o texto integral Obter o texto integral

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer Por Robles-Zurita, José, Boyd, Kathleen A., Briggs, Andrew H., Iveson, Timothy, Kerr, Rachel S., Saunders, Mark P., Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Segelov, Eva, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Pearson, Sarah, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S., Hughes, Rob, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet S, Paul, James

Obter o texto integral Obter o texto integral Obter o texto integral

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Por Iveson, Timothy, Boyd, Kathleen A, Kerr, Rachel S, Robles-Zurita, Jose, Saunders, Mark P, Briggs, Andrew H, Cassidy, Jim, Hollander, Niels Henrik, Tabernero, Josep, Haydon, Andrew, Glimelius, Bengt, Harkin, Andrea, Allan, Karen, McQueen, John, Pearson, Sarah, Waterston, Ashita, Medley, Louise, Wilson, Charles, Ellis, Richard, Essapen, Sharadah, Dhadda, Amandeep S, Harrison, Mark, Falk, Stephen, Raouf, Sherif, Rees, Charlotte, Olesen, Rene K, Propper, David, Bridgewater, John, Azzabi, Ashraf, Farrugia, David, Webb, Andrew, Cunningham, David, Hickish, Tamas, Weaver, Andrew, Gollins, Simon, Wasan, Harpreet, Paul, James

Obter o texto integral Obter o texto integral Obter o texto integral